Aquarius Surgical Technologies Inc.
AQQRF
$0.0042
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.40K | 27.50K | 17.90K | 25.80K | 41.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.40K | 27.50K | 17.90K | 25.80K | 41.20K |
| Cost of Revenue | 4.90K | 13.00K | 9.50K | 11.70K | 19.10K |
| Gross Profit | 4.50K | 14.50K | 8.40K | 14.10K | 22.10K |
| SG&A Expenses | 131.60K | 108.10K | 106.90K | 111.70K | 90.60K |
| Depreciation & Amortization | 5.20K | 5.40K | 5.70K | 5.70K | 5.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 141.70K | 126.50K | 122.10K | 129.10K | 115.40K |
| Operating Income | -132.30K | -99.00K | -104.20K | -103.40K | -74.20K |
| Income Before Tax | -173.80K | -161.60K | -161.90K | -157.50K | -135.80K |
| Income Tax Expenses | -- | -- | -- | 5.20K | -- |
| Earnings from Continuing Operations | -173.80K | -161.60K | -161.90K | -162.70K | -135.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -173.80K | -161.60K | -161.90K | -162.70K | -135.80K |
| EBIT | -132.30K | -99.00K | -104.20K | -103.40K | -74.20K |
| EBITDA | -127.10K | -93.60K | -103.40K | -102.60K | -68.50K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 27.60M | 27.60M | 27.60M | 27.60M | 27.60M |
| Average Diluted Shares Outstanding | 27.60M | 27.60M | 27.60M | 27.60M | 27.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
